Haleon (HLN) Asset Utilization Ratio (2023 - 2025)
Haleon's (HLN) quarterly Asset Utilization Ratio came in at 0.57 in Q4 2025, up 16.75% on a QoQ basis from 0.49 in Q4 2023.
Haleon (HLN) Asset Utilization Ratio (2023 - 2025) Analysis & Trends
Haleon (HLN) has 2 years of Asset Utilization Ratio data on file, last reported at 0.57 in Q4 2025.
- Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.57 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.57 (changed N/A YoY) and the FY2025 annual result came in at 0.34, up 0.96% from the prior year.
- Asset Utilization Ratio advanced to 0.57 in Q4 2025, from 0.49 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.57 in Q4 2025 to a low of 0.49 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 0.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.57 |
| Dec 31, 2023 | 0.49 |